Ranibizumab ophthalmic for Macular Edema Following Retinal Vein Occlusion User Reviews
Brand names: Lucentis, Cimerli, Byooviz, Susvimo
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about ranibizumab ophthalmic
- Check interactions
- Compare alternatives
- Reviews (18)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Patient resources
- Ranibizumab ophthalmic drug information
- Ranibizumab (Advanced Reading)
- Ranibizumab-eqrn (Advanced Reading)
- Ranibizumab
Other brands
Lucentis, Cimerli, Byooviz, Susvimo
Professional resources
Other brands
Lucentis, Cimerli, Byooviz, Susvimo
"I was diagnosed with retinal vein occlusion in my right eye. I am legally blind in my left eye since birth. I was afraid I would lose the sight in my right eye. My doctor started me on Lucentis every 4 weeks for 12 months, then went to 6 weeks, then 8 weeks, and finally 10 weeks. I have preserved my sight in the right eye. No real side effects that would cause me to stop treatment."